Thai Nguyen City

Resilience Network


You are here

Medical Testing

Both Paxlovid, molnupiravir lower COVID Omicron deaths, hospitalizations -- studies

Two new studies describe the benefits of the antiviral drugs nirmatrelvir-ritonavir (Paxlovid) and molnupiravir in reducing SARS-CoV-2 Omicron hospitalizations and death, with one finding that the former is more effective than the latter at lowering death rates.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Medical Testing
howdy folks
Page loaded in 0.648 seconds.